Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond

Area of Science:

• Oncology
• Immunology
• Biomedical Science

Background:

• The symposium convened experts in immune monitoring and oncology to discuss the evolution and future of immune assessment in cancer research.
• Keynote lectures highlighted the historical development, current state, and future directions of immune monitoring technologies and their impact on immuno-oncology.

Framework:

• A classification of immune monitoring technologies was presented, ranging from established protocols to experimental approaches, with an emphasis on the need for assay standardization.
• Physiological differences in CD8 T cells relevant to anti-tumor responses were discussed, alongside the critical distinction between T cell viability and functionality within the tumor microenvironment.

Implementation:

• The importance of monitoring dendritic cell metabolic function for tumor vaccine efficacy was emphasized.
• Recent advancements in glioblastoma treatment were showcased, demonstrating how monitoring techniques refine patient selection for clinical trials.
• The role of hypoxia in the tumor microenvironment and its impact on immune cell function were explored.

Implications:

• Immune monitoring is essential for guiding the development of effective immunotherapeutic strategies.
• Future directions in immune monitoring were discussed, highlighting its continued role in advancing cancer treatment.
• Harmonization of immune monitoring assays is critical for reliable and reproducible results in immuno-oncology research.